Dose-Adjusted EPOCH-R in Aggressive B-Cell Lymphomas: Efficacy, Molecular Prognostic Factors, and Real-World Outcomes from a Multicenter Turkish Cohort-A Turkish Oncology Group (TOG) Study.
- DOI
- 10.3390/medicina62061117
- Published
- 2026 Jun 8
- Container
- Medicina (Kaunas, Lithuania)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/medicina62061117,
title = {Dose-Adjusted EPOCH-R in Aggressive B-Cell Lymphomas: Efficacy, Molecular Prognostic Factors, and Real-World Outcomes from a Multicenter Turkish Cohort-A Turkish Oncology Group (TOG) Study.},
author = {Kidi MM and Asoglu H and Soysal M and Koseci T and Kara IO and Sahin B and Paydas S and Aykan MB and Karadurmus N and Barista I and Akin S and Kus F and Akay MO and Kalyon H and Boga C and Ozdogu H and Bayram E},
year = {2026},
journal = {Medicina (Kaunas, Lithuania)},
doi = {10.3390/medicina62061117},
url = {https://doi.org/10.3390/medicina62061117}
}RIS
TY - JOUR TI - Dose-Adjusted EPOCH-R in Aggressive B-Cell Lymphomas: Efficacy, Molecular Prognostic Factors, and Real-World Outcomes from a Multicenter Turkish Cohort-A Turkish Oncology Group (TOG) Study. AU - Kidi MM AU - Asoglu H AU - Soysal M AU - Koseci T AU - Kara IO AU - Sahin B AU - Paydas S AU - Aykan MB AU - Karadurmus N AU - Barista I AU - Akin S AU - Kus F AU - Akay MO AU - Kalyon H AU - Boga C AU - Ozdogu H AU - Bayram E PY - 2026 JO - Medicina (Kaunas, Lithuania) DO - 10.3390/medicina62061117 UR - https://doi.org/10.3390/medicina62061117 ER -
APA
MM, K., H, A., M, S., T, K., IO, K., B, S., S, P., MB, A., N, K., I, B., S, A., F, K., MO, A., H, K., C, B., H, O., & E, B. (2026). Dose-Adjusted EPOCH-R in Aggressive B-Cell Lymphomas: Efficacy, Molecular Prognostic Factors, and Real-World Outcomes from a Multicenter Turkish Cohort-A Turkish Oncology Group (TOG) Study.. Medicina (Kaunas, Lithuania). https://doi.org/10.3390/medicina62061117
Source records
- pubmed · retrieved 2026-09-25T20:12:11.563Z